HEC96719

Add links
Source: Wikipedia, the free encyclopedia.
HEC96719
Legal status
Legal status
  • Investigational
Identifiers
  • 3-[[5-Cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]spiro[6H-[1]benzoxepino[3,2-b]pyridine-5,1'-cyclopropane]-9-carboxylic acid
PubChem CID
Chemical and physical data
FormulaC29H22Cl2N2O5
Molar mass549.40 g·mol−1

HEC96719 is a tricyclic farnesoid X receptor agonist developed for non-alcoholic steatohepatitis.[1][2][3]

References

  1. S2CID 245577605
    .
  2. S2CID 253329947
    .
  3. S2CID 256825486
    .
Retrieved from "https://en.wikipedia.org/w/index.php?title=HEC96719&oldid=1193944827"